1-20 of 139
Clinical Trials Corner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

PROGRESS IV: Will Ruxolitinib Emerge as an Alternative to Post-Transplant Cyclophosphamide in Reduced-Intensity Conditioning Transplantation?

Free
Alfonso Molina, MD, MPH, Lori Muffly, MD, MS
Journal: The Hematologist
The Hematologist (2025) 22 (6)
https://doi.org/10.1182/hem.V22.6.2025610
Published: 2025
Articles

Mechanical Thrombectomy for the Prevention of Post-Thrombotic Syndrome: Outcomes Matter

Free
Harish Eswaran, MD, Samuel R. Wilson, MD, MSCR
Journal: The Hematologist
The Hematologist (2025) 22 (5)
https://doi.org/10.1182/hem.V22.5.2025513
Published: 2025
Articles

Bending the Needle: Phase III MANGROVE Study in First-Line Mantle Cell Lymphoma

Free
Tycel Phillips, MD
Journal: The Hematologist
The Hematologist (2025) 22 (5)
https://doi.org/10.1182/hem.V22.5.2025512
Published: 2025
Articles

Combination of Antibody Drug Conjugate With Bispecific T-Cell Engager for Relapsed Large B-Cell Lymphoma: A Lethal One-Two Punch?

Free
Brian T. Hill, MD, PhD
Journal: The Hematologist
The Hematologist (2025) 22 (5)
https://doi.org/10.1182/hem.V22.5.2025514
Published: 2025
Articles

Hope for a New Standard of Care for Newly Diagnosed Diffuse Large B-Cell Lymphoma

Free
Tycel Phillips, MD
Journal: The Hematologist
The Hematologist (2025) 22 (4)
https://doi.org/10.1182/hem.V22.4.202542
Published: 2025
Articles

Changing Landscape of Management of Warm Autoimmune Hemolytic Anemia

Free
Surbhi Shah, MD
Journal: The Hematologist
The Hematologist (2025) 22 (4)
https://doi.org/10.1182/hem.V22.4.202543
Published: 2025
Articles

Can Abelacimab Attenuate the Risk of Bleeding in Patients With Atrial Fibrillation?

Free
Michael Scott, MD, MHPE
Journal: The Hematologist
The Hematologist (2025) 22 (3)
https://doi.org/10.1182/hem.V22.3.202537
Published: 2025
Articles

Targeting the Rare: A New Therapy for Pediatric Acute Myeloid Leukemia With CBFA2T3-GLIS2 Fusions

Free
Scott Furlan, MD
Journal: The Hematologist
The Hematologist (2025) 22 (2)
https://doi.org/10.1182/hem.V22.2.202529
Published: 2025
Articles

BLySfully BAFFled: The Expanding Immune Thrombocytopenia Armamentarium

Free
Richard C. Godby, MD, Surbhi Shah, MD
Journal: The Hematologist
The Hematologist (2025) 22 (1)
https://doi.org/10.1182/hem.V22.1.2025215
Published: 2025
Articles

An Alternative to ‘Watch and Wait’ for Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma?

Free
Brian T. Hill, MD, PhD
Journal: The Hematologist
The Hematologist (2024) 21 (6)
https://doi.org/10.1182/hem.V21.6.2024614
Published: 2024
Articles

Liquid Biopsy in Diffuse Large B-Cell Lymphoma

Free
Elizabeth L. Courville, MD
Journal: The Hematologist
The Hematologist (2024) 21 (6)
https://doi.org/10.1182/hem.V21.6.2024615
Published: 2024
Articles

First line therapy for primary immune thrombocytopenia — beyond steroids…

Free
Zoey I. Harris, MD, Surbhi Shah, MBBS, MD
Journal: The Hematologist
The Hematologist (2024) 21 (4)
https://doi.org/10.1182/hem.V21.4.2024418
Published: 2024
Articles

Targeting the Natural History of Clonal Hematopoiesis

Free
Christine M. McMahon, MD
Journal: The Hematologist
The Hematologist (2024) 21 (4)
https://doi.org/10.1182/hem.V21.4.2024414
Published: 2024
Articles

Ambulatory Management of Thrombotic Thrombocytopenia Purpura: Will We Get There?

Free
Samuel R. Wilson, MD, MSCR, Raj S. Kasthuri, MBBS
Journal: The Hematologist
The Hematologist (2024) 21 (4)
https://doi.org/10.1182/hem.V21.4.2024419
Published: 2024
Articles

Bispecific Antibodies in Frontline Large B-cell Lymphoma: Can We Do Better Than Pola-R-CHP?

Free
Avyakta Kallam, MD, Alex Herrera, MD
Journal: The Hematologist
The Hematologist (2024) 21 (3)
https://doi.org/10.1182/hem.V21.3.202436
Published: 2024
Articles

Risk-stratified Treatment for Pediatric Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

Free
Elliot Stieglitz, MD, Lauren Pommert, MD, MS
Journal: The Hematologist
The Hematologist (2024) 21 (2)
https://doi.org/10.1182/hem.V21.2.202427
Published: 2024
Articles

Bitopertin for Erythropoietic Protoporphyria: A New Paradigm — and New Hope — for a Rare, Devastating Disease

Free
Michael Scott, MD
Journal: The Hematologist
The Hematologist (2023) 20 (6)
https://doi.org/10.1182/hem.V20.6.2023610
Published: 2023
Articles

MAHOGANY: Will it Establish Zanbrutinib, a Second-generation Bruton Tyrosine Kinase Inhibitor, as a Preferred Targeted Therapy for Relapsed/Refractory Follicular and Marginal Zone Lymphomas?

Free
Loretta J. Nastoupil, MD
Journal: The Hematologist
The Hematologist (2023) 20 (6)
https://doi.org/10.1182/hem.V20.6.202369
Published: 2023
Articles

Two National Clinical Trials Poised to Expand the Role of Bone Marrow Transplant in Newly Diagnosed Severe Aplastic Anemia

Free
Lori Muffly, MD, MS
Journal: The Hematologist
The Hematologist (2023) 20 (6)
https://doi.org/10.1182/hem.V20.6.202368
Published: 2023
Articles

Rilzabrutinib for Persistent ITP: New Kid on the Block?

Free
Michael Scott, MD
Journal: The Hematologist
The Hematologist (2023) 20 (5)
https://doi.org/10.1182/hem.V20.5.202352
Published: 2023